Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvanted vs Nonadjuvanted Influenza Vaccine in HSCT
NCT02560909Phase 4Completed
- Sponsor
- University Health Network
- Start
- Oct 2015
- Primary completion
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, randomised trial of Fluzone Trivalent in influenza (2 arms), sponsored by University Health Network. Primary endpoint: Rates of seroconversion at 4 weeks. Started Oct 2015; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02560909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560909.